BIO-11002

N/A

Report date: 2025/01/26 18:38:57

Base Information

Drug NameBIO-11002
Drug Alias NameBIO-11002
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMyristoylated alanine-rich C-kinase substrate inhibitors
TargetsMyristoylated alanine-rich C-kinase substrate
Therapy Area/IndicationsLung DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiomarck Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiomarck Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsLung Diseases

Other Information

ATC CodeN/A
Related LinksN/A